This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Provides guidelines related to opioid dependence that aim to: reduce global barriers to effective treatment; contribute to the development of evidence-based, ethical treatment policies; contribute to improvement of the quality of pharmacological treatment; and facilitate implementation of effective treatment policies and programs.
Explains patient rights and the Federal laws that protect people receiving MAT for opioid addiction. Describes who is protected by these laws and what they cover, including employment, housing, services, and public accommodations.
Provides guidance on the use of buprenorphine among a number of topics, including physiology and pharmacology of opioids, opioid addiction, and buprenorphine treatment; screening and assessment of OUDs; protocols for buprenorphine treatment; management of special populations; and policies and procedures related to DATA 2000.
PCSS clinical experts have created a new Performance-in-Practice (PIP) activity that will help you identify and address gaps in your practice treating patients with opioid use disorder (OUD).
Provides policymakers, State and local officials, and other community stakeholders with key questions to consider before engaging in efforts to increase access to MAT for addiction in their communities
Email Updates